Slideshow: 2018 US Cannabis Business Year in Review
2018 marked the historic legalization of recreational marijuana in Canada, the end of hemp prohibition in the United…
News December 28
Latest In: Tilray
Growth slows for German medical cannabis market in third quarter
Demand for medical marijuana in Germany continued to increase in the third quarter, albeit at a slower pace…
News December 27
Budweiser maker AB InBev teams with Tilray in $100 million deal to research marijuana-infused drinks
Two commercial giants from the worlds of beer and marijuana are teaming up to spend $100 million to…
News December 19
Canadian medical cannabis firm Tilray eyes global reach in deal with Novartis subsidiary
British Columbia-based Tilray reached an agreement with a subsidiary of Swiss pharmaceutical giant Novartis AG in which the…
News December 18
Howard Dean, Lloyd Axworthy join marijuana firm’s International Advisory Board
Amid growing scrutiny of cross-border deals in the marijuana industry, Nanaimo, British Columbia-based Tilray has formed an International…
News December 13
IGC Resources, Westleaf Cannabis close CA$20M raise, including Tilray investment
Alberta marijuana companies IGC Resources (TSXV: IGC.H) and Westleaf Cannabis closed a brokered private placement of 20 million…
News December 6
Lawsuit throws German cannabis program into limbo; deadline delayed to Dec. 11
Another lawsuit challenging the application process to grow medical cannabis in Germany could throw the already-delayed domestic cultivation plans…
News November 15
Aphria seeks EU GMP certification before closing deal for German distributor
Aphria, one of Canada’s largest medical cannabis companies, aims to obtain an essential European quality standard certification before…
News November 9
Canadian cannabis firm Aphria approved for NYSE listing
Aphria, one of Canada’s largest cannabis producers, has been approved to list its shares on the New York…
News October 30Featured
1
Latest Sponsored
